Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis

High fibroblast growth factor 23 (FGF23) level in patients with chronic kidney disease is associated with increased cardiovascular disease and mortality. phosphate binders, iron supplements, calcimimetics, parathyroidectomy, dialysis techniques, and preservation of residual renal function (RRF) were found to be effective.

Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group study

Tyrosine kinase 2 (TYK2) signaling has previously shown therapeutic potential in the treatment of psoriasis. The primary objective of this study was to assess the safety and tolerability of the TYK2 inhibitor PF-06826647. The area under the concentration-time curve over the dosing interval and the maximum concentration increased in a less than dose-proportional manner with increasing dose from 100 mg to 400 mg.

Health Services Use by Children in the Welfare System Who Died by Suicide

Suicide decedents with a history of child welfare system involvement could be targeted for prevention strategies. The study included youth aged 5 to 21 who died by suicide and had an open case in Ohio's Statewide Automated Child Welfare Information System. Suicide decedents were twice as likely to access mental health services in the 1 and 6 months before death, regardless of the health care setting. Suicide decedents involved in the child welfare system were more likely to use mental and physic

Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance—Does Magnetic Resonance Imaging Have a Role?

The National Comprehensive Cancer Network recommends that selected men with grade group 2 prostate cancer be considered for active surveillance. The information could be used to inform biopsy strategy, counsel patients, on treatment options, and guide strategies for those on active surveillance.

Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2‐year randomized study

The study included 61 postmenopausal women and men above 50 years discontinuing denosumab after 4.6±1.6 years. After 12 months, lumbar spine BMD decreased by 4.0±0.8%, 4.1°C to 4.3°C in the 6M, 9M, and OBS groups. Treatment with ZOL did not fully prevent increased bone turnover and bone loss during the first year, however, CTX remained with the reference range and BMD was maintained during the second year.

Nanoparticles in pregnancy: the next frontier in reproductive therapeutics

Pre-clinical research in the development of nanoparticle therapeutic delivery is being undertaken in many fields of reproductive medicine. Non-hormonal-targeted nanoparticle therapy for fibroids and endometriosis may provide fertility-sparing medical management. Nanotherapeutic delivery offers options to stably deliver silencing RNA and microRNA inhibitors to the placenta. Alternatively, targeted delivery of drugs to the fetus may minimize side effects for the mother.

Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study

Prehospital stroke scales have been proposed to select patients with large-vessel occlusion for direct transport. The NIHSS as assessed by a clinician in the emergency department did somewhat better than the pre Hospital stroke scales. Further studies are needed to investigate whether the use of these scales in regional transportation strategies can optimize outcomes.

A single-cell map for the transcriptomic signatures of peripheral blood mononuclear cells in end-stage renal disease

Immune aberrations in End-stage renal disease are characterized by systemic inflammation and immune deficiency. Study compared cells from ESRD patients and healthy individuals. Compared cells revealed multiple changes in biological processes. An increase in inflammation response, complement cascade, and cellular metabolism was observed. The generation of larger single-cell datasets will complement the current map and drive advances in therapies that manipulate immune cell function in ESRD.

Departments

Recent Posts